nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Sibutramine—obesity	0.128	0.27	CbGbCtD
Dofetilide—CYP3A4—Benzphetamine—obesity	0.0972	0.204	CbGbCtD
Dofetilide—CYP3A4—Bupropion—obesity	0.0826	0.174	CbGbCtD
Dofetilide—CYP3A4—Orlistat—obesity	0.0674	0.142	CbGbCtD
Dofetilide—CYP3A4—Cimetidine—obesity	0.0607	0.127	CbGbCtD
Dofetilide—CYP3A4—Topiramate—obesity	0.0397	0.0834	CbGbCtD
Dofetilide—Block heart—Cimetidine—obesity	0.009	0.0232	CcSEcCtD
Dofetilide—Facial paralysis—Sibutramine—obesity	0.00858	0.0221	CcSEcCtD
Dofetilide—Liver injury—Phenylpropanolamine—obesity	0.00766	0.0198	CcSEcCtD
Dofetilide—VIIth nerve paralysis—Sibutramine—obesity	0.00665	0.0172	CcSEcCtD
Dofetilide—Hepatocellular injury—Phenylpropanolamine—obesity	0.00645	0.0166	CcSEcCtD
Dofetilide—Liver injury—Cimetidine—obesity	0.00607	0.0157	CcSEcCtD
Dofetilide—Cerebral ischaemia—Sibutramine—obesity	0.00564	0.0146	CcSEcCtD
Dofetilide—Bundle branch block—Sibutramine—obesity	0.00541	0.014	CcSEcCtD
Dofetilide—Sudden death—Sibutramine—obesity	0.00533	0.0138	CcSEcCtD
Dofetilide—Atrioventricular block—Cimetidine—obesity	0.00526	0.0136	CcSEcCtD
Dofetilide—KCNJ12—cardiovascular system—obesity	0.00499	0.282	CbGeAlD
Dofetilide—Cardiac failure—Phentermine—obesity	0.00459	0.0118	CcSEcCtD
Dofetilide—Cerebrovascular accident—Phentermine—obesity	0.00457	0.0118	CcSEcCtD
Dofetilide—Sweating—Benzphetamine—obesity	0.00444	0.0115	CcSEcCtD
Dofetilide—Cardiac arrest—Phentermine—obesity	0.00426	0.011	CcSEcCtD
Dofetilide—Supraventricular tachycardia—Sibutramine—obesity	0.00416	0.0107	CcSEcCtD
Dofetilide—Sweating—Phendimetrazine—obesity	0.00405	0.0104	CcSEcCtD
Dofetilide—Cerebrovascular accident—Diethylpropion—obesity	0.00397	0.0103	CcSEcCtD
Dofetilide—Torsade de pointes—Sibutramine—obesity	0.00389	0.01	CcSEcCtD
Dofetilide—Respiratory tract infection—Bupropion—obesity	0.00378	0.00977	CcSEcCtD
Dofetilide—Angina pectoris—Phentermine—obesity	0.00377	0.00973	CcSEcCtD
Dofetilide—Supraventricular tachycardia—Bupropion—obesity	0.00363	0.00937	CcSEcCtD
Dofetilide—Ventricular fibrillation—Sibutramine—obesity	0.00356	0.0092	CcSEcCtD
Dofetilide—Acute coronary syndrome—Phentermine—obesity	0.0034	0.00878	CcSEcCtD
Dofetilide—Myocardial infarction—Phentermine—obesity	0.00338	0.00873	CcSEcCtD
Dofetilide—Palpitations—Methamphetamine—obesity	0.00332	0.00856	CcSEcCtD
Dofetilide—Palpitations—Benzphetamine—obesity	0.0032	0.00826	CcSEcCtD
Dofetilide—KCNK2—adrenal cortex—obesity	0.00313	0.176	CbGeAlD
Dofetilide—Accidental injury—Sibutramine—obesity	0.00308	0.00796	CcSEcCtD
Dofetilide—Cough increased—Sibutramine—obesity	0.00298	0.00769	CcSEcCtD
Dofetilide—Rosiglitazone—PPARG—obesity	0.00293	0.397	CrCbGaD
Dofetilide—Palpitations—Phendimetrazine—obesity	0.00291	0.00753	CcSEcCtD
Dofetilide—Arrhythmia—Phenylpropanolamine—obesity	0.00289	0.00746	CcSEcCtD
Dofetilide—Hyperhidrosis—Benzphetamine—obesity	0.00286	0.00737	CcSEcCtD
Dofetilide—Liver injury—Bupropion—obesity	0.00283	0.0073	CcSEcCtD
Dofetilide—Insomnia—Methamphetamine—obesity	0.00277	0.00715	CcSEcCtD
Dofetilide—Ventricular tachycardia—Sibutramine—obesity	0.00273	0.00704	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—NPC1—obesity	0.00271	0.0243	CbGpPWpGaD
Dofetilide—Accidental injury—Bupropion—obesity	0.00269	0.00694	CcSEcCtD
Dofetilide—Insomnia—Benzphetamine—obesity	0.00267	0.0069	CcSEcCtD
Dofetilide—CYP3A4—Felbamate Metabolism—CYP2E1—obesity	0.00264	0.0236	CbGpPWpGaD
Dofetilide—Bradycardia—Cimetidine—obesity	0.00261	0.00674	CcSEcCtD
Dofetilide—Hyperhidrosis—Phendimetrazine—obesity	0.0026	0.00672	CcSEcCtD
Dofetilide—Cough increased—Bupropion—obesity	0.0026	0.00671	CcSEcCtD
Dofetilide—KCNK2—adipose tissue—obesity	0.00252	0.142	CbGeAlD
Dofetilide—Insomnia—Phendimetrazine—obesity	0.00243	0.00629	CcSEcCtD
Dofetilide—Respiratory tract infection—Topiramate—obesity	0.00241	0.00622	CcSEcCtD
Dofetilide—Arrhythmia—Diethylpropion—obesity	0.00241	0.00621	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—GABRA6—obesity	0.0024	0.0215	CbGpPWpGaD
Dofetilide—Anxiety—Phenylpropanolamine—obesity	0.00239	0.00617	CcSEcCtD
Dofetilide—Dronedarone—ADRB1—obesity	0.00238	0.324	CrCbGaD
Dofetilide—Palpitations—Phentermine—obesity	0.00238	0.00615	CcSEcCtD
Dofetilide—Hepatocellular injury—Bupropion—obesity	0.00238	0.00614	CcSEcCtD
Dofetilide—Hypertension—Phentermine—obesity	0.00233	0.00601	CcSEcCtD
Dofetilide—Chest pain—Phentermine—obesity	0.0023	0.00593	CcSEcCtD
Dofetilide—KCNK2—adrenal gland—obesity	0.00226	0.127	CbGeAlD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—GLUL—obesity	0.00224	0.02	CbGpPWpGaD
Dofetilide—Oedema—Phentermine—obesity	0.0022	0.00568	CcSEcCtD
Dofetilide—Injury—Sibutramine—obesity	0.00215	0.00556	CcSEcCtD
Dofetilide—Abdominal pain—Phendimetrazine—obesity	0.00213	0.00549	CcSEcCtD
Dofetilide—KCNK2—Potassium Channels—KCNMA1—obesity	0.00211	0.0188	CbGpPWpGaD
Dofetilide—Diarrhoea—Methamphetamine—obesity	0.0021	0.00541	CcSEcCtD
Dofetilide—Insomnia—Phenylpropanolamine—obesity	0.00208	0.00537	CcSEcCtD
Dofetilide—Palpitations—Diethylpropion—obesity	0.00207	0.00535	CcSEcCtD
Dofetilide—Dyspnoea—Phenylpropanolamine—obesity	0.00205	0.00529	CcSEcCtD
Dofetilide—Dizziness—Methamphetamine—obesity	0.00203	0.00523	CcSEcCtD
Dofetilide—Diarrhoea—Benzphetamine—obesity	0.00202	0.00522	CcSEcCtD
Dofetilide—Cerebrovascular accident—Sibutramine—obesity	0.00202	0.00522	CcSEcCtD
Dofetilide—Chest pain—Diethylpropion—obesity	0.002	0.00516	CcSEcCtD
Dofetilide—Insomnia—Phentermine—obesity	0.00199	0.00514	CcSEcCtD
Dofetilide—Anxiety—Diethylpropion—obesity	0.00199	0.00514	CcSEcCtD
Dofetilide—Dizziness—Benzphetamine—obesity	0.00195	0.00504	CcSEcCtD
Dofetilide—Migraine—Sibutramine—obesity	0.00195	0.00503	CcSEcCtD
Dofetilide—Headache—Methamphetamine—obesity	0.00192	0.00495	CcSEcCtD
Dofetilide—Arthralgia—Cimetidine—obesity	0.0019	0.00491	CcSEcCtD
Dofetilide—Anxiety—Cimetidine—obesity	0.00189	0.00489	CcSEcCtD
Dofetilide—Cardiac arrest—Sibutramine—obesity	0.00188	0.00486	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—CES1—obesity	0.00188	0.0168	CbGpPWpGaD
Dofetilide—Injury—Bupropion—obesity	0.00188	0.00485	CcSEcCtD
Dofetilide—Hyperhidrosis—Diethylpropion—obesity	0.00185	0.00478	CcSEcCtD
Dofetilide—Headache—Benzphetamine—obesity	0.00185	0.00478	CcSEcCtD
Dofetilide—Diarrhoea—Phendimetrazine—obesity	0.00184	0.00475	CcSEcCtD
Dofetilide—Dizziness—Phendimetrazine—obesity	0.00178	0.0046	CcSEcCtD
Dofetilide—Influenza—Orlistat—obesity	0.00177	0.00457	CcSEcCtD
Dofetilide—Cerebrovascular accident—Bupropion—obesity	0.00176	0.00455	CcSEcCtD
Dofetilide—Nausea—Benzphetamine—obesity	0.00175	0.00453	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Diethylpropion—obesity	0.00174	0.0045	CcSEcCtD
Dofetilide—Abdominal pain—Phentermine—obesity	0.00174	0.00449	CcSEcCtD
Dofetilide—Insomnia—Diethylpropion—obesity	0.00173	0.00447	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—GLUL—obesity	0.00171	0.0153	CbGpPWpGaD
Dofetilide—Influenza—Sibutramine—obesity	0.00171	0.00442	CcSEcCtD
Dofetilide—Dyspnoea—Diethylpropion—obesity	0.00171	0.00441	CcSEcCtD
Dofetilide—Migraine—Bupropion—obesity	0.0017	0.00439	CcSEcCtD
Dofetilide—Headache—Phendimetrazine—obesity	0.00169	0.00435	CcSEcCtD
Dofetilide—KCNJ12—Potassium Channels—GNB3—obesity	0.00168	0.0151	CbGpPWpGaD
Dofetilide—Angina pectoris—Sibutramine—obesity	0.00167	0.0043	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Cimetidine—obesity	0.00166	0.00428	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—SLC22A1—obesity	0.00165	0.0147	CbGpPWpGaD
Dofetilide—Nausea—Phendimetrazine—obesity	0.0016	0.00413	CcSEcCtD
Dofetilide—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.00159	0.0142	CbGpPWpGaD
Dofetilide—Asthenia—Phentermine—obesity	0.00158	0.00408	CcSEcCtD
Dofetilide—Atrioventricular block—Topiramate—obesity	0.00156	0.00403	CcSEcCtD
Dofetilide—Urinary tract infection—Orlistat—obesity	0.00153	0.00396	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—GABRA6—obesity	0.00153	0.0137	CbGpPWpGaD
Dofetilide—Dizziness—Phenylpropanolamine—obesity	0.00152	0.00393	CcSEcCtD
Dofetilide—Diarrhoea—Phentermine—obesity	0.00151	0.00389	CcSEcCtD
Dofetilide—Acute coronary syndrome—Sibutramine—obesity	0.0015	0.00388	CcSEcCtD
Dofetilide—Myocardial infarction—Sibutramine—obesity	0.0015	0.00386	CcSEcCtD
Dofetilide—Influenza—Bupropion—obesity	0.00149	0.00385	CcSEcCtD
Dofetilide—Urinary tract infection—Sibutramine—obesity	0.00148	0.00383	CcSEcCtD
Dofetilide—Sweating—Sibutramine—obesity	0.00146	0.00378	CcSEcCtD
Dofetilide—Dizziness—Phentermine—obesity	0.00146	0.00376	CcSEcCtD
Dofetilide—Rash—Phenylpropanolamine—obesity	0.00145	0.00374	CcSEcCtD
Dofetilide—Dermatitis—Phenylpropanolamine—obesity	0.00145	0.00374	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—KCNMA1—obesity	0.00145	0.0129	CbGpPWpGaD
Dofetilide—Bradycardia—Sibutramine—obesity	0.00139	0.0036	CcSEcCtD
Dofetilide—Oedema peripheral—Orlistat—obesity	0.00139	0.0036	CcSEcCtD
Dofetilide—Rash—Phentermine—obesity	0.00139	0.00358	CcSEcCtD
Dofetilide—Dermatitis—Phentermine—obesity	0.00139	0.00358	CcSEcCtD
Dofetilide—Headache—Phentermine—obesity	0.00138	0.00356	CcSEcCtD
Dofetilide—Nausea—Phenylpropanolamine—obesity	0.00137	0.00353	CcSEcCtD
Dofetilide—Oedema peripheral—Sibutramine—obesity	0.00135	0.00348	CcSEcCtD
Dofetilide—Acute coronary syndrome—Bupropion—obesity	0.00131	0.00339	CcSEcCtD
Dofetilide—Diarrhoea—Diethylpropion—obesity	0.00131	0.00338	CcSEcCtD
Dofetilide—Nausea—Phentermine—obesity	0.00131	0.00337	CcSEcCtD
Dofetilide—Asthenia—Cimetidine—obesity	0.00131	0.00337	CcSEcCtD
Dofetilide—Myocardial infarction—Bupropion—obesity	0.0013	0.00337	CcSEcCtD
Dofetilide—Urinary tract infection—Bupropion—obesity	0.00129	0.00334	CcSEcCtD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	0.00128	0.0114	CbGpPWpGaD
Dofetilide—Sweating—Bupropion—obesity	0.00128	0.00329	CcSEcCtD
Dofetilide—Dizziness—Diethylpropion—obesity	0.00127	0.00327	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—SLC22A1—obesity	0.00126	0.0113	CbGpPWpGaD
Dofetilide—Diarrhoea—Cimetidine—obesity	0.00125	0.00322	CcSEcCtD
Dofetilide—Arrhythmia—Sibutramine—obesity	0.00122	0.00316	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—BCHE—obesity	0.00122	0.0109	CbGpPWpGaD
Dofetilide—Rash—Diethylpropion—obesity	0.00121	0.00312	CcSEcCtD
Dofetilide—Dermatitis—Diethylpropion—obesity	0.00121	0.00311	CcSEcCtD
Dofetilide—Dizziness—Cimetidine—obesity	0.0012	0.00311	CcSEcCtD
Dofetilide—Headache—Diethylpropion—obesity	0.0012	0.0031	CcSEcCtD
Dofetilide—Back pain—Orlistat—obesity	0.00119	0.00308	CcSEcCtD
Dofetilide—Oedema peripheral—Bupropion—obesity	0.00118	0.00304	CcSEcCtD
Dofetilide—Back pain—Sibutramine—obesity	0.00115	0.00298	CcSEcCtD
Dofetilide—Rash—Cimetidine—obesity	0.00115	0.00296	CcSEcCtD
Dofetilide—Dermatitis—Cimetidine—obesity	0.00115	0.00296	CcSEcCtD
Dofetilide—Headache—Cimetidine—obesity	0.00114	0.00295	CcSEcCtD
Dofetilide—Nausea—Diethylpropion—obesity	0.00114	0.00294	CcSEcCtD
Dofetilide—Angioedema—Orlistat—obesity	0.00113	0.00291	CcSEcCtD
Dofetilide—KCNH2—islet of Langerhans—obesity	0.0011	0.0621	CbGeAlD
Dofetilide—Rosiglitazone—ALB—obesity	0.0011	0.149	CrCbGaD
Dofetilide—Angioedema—Sibutramine—obesity	0.00109	0.00281	CcSEcCtD
Dofetilide—Palpitations—Orlistat—obesity	0.00109	0.00281	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—GLUL—obesity	0.00109	0.00973	CbGpPWpGaD
Dofetilide—Migraine—Topiramate—obesity	0.00108	0.00279	CcSEcCtD
Dofetilide—Nausea—Cimetidine—obesity	0.00108	0.00279	CcSEcCtD
Dofetilide—Cough—Orlistat—obesity	0.00108	0.00278	CcSEcCtD
Dofetilide—Syncope—Sibutramine—obesity	0.00107	0.00276	CcSEcCtD
Dofetilide—KCNK2—Potassium Channels—GNB3—obesity	0.00107	0.00957	CbGpPWpGaD
Dofetilide—Arrhythmia—Bupropion—obesity	0.00107	0.00275	CcSEcCtD
Dofetilide—Palpitations—Sibutramine—obesity	0.00105	0.00272	CcSEcCtD
Dofetilide—Chest pain—Orlistat—obesity	0.00105	0.00271	CcSEcCtD
Dofetilide—Loss of consciousness—Sibutramine—obesity	0.00105	0.00271	CcSEcCtD
Dofetilide—Anxiety—Orlistat—obesity	0.00105	0.0027	CcSEcCtD
Dofetilide—Cough—Sibutramine—obesity	0.00104	0.00269	CcSEcCtD
Dofetilide—Hypertension—Sibutramine—obesity	0.00103	0.00266	CcSEcCtD
Dofetilide—Arthralgia—Sibutramine—obesity	0.00102	0.00262	CcSEcCtD
Dofetilide—Chest pain—Sibutramine—obesity	0.00102	0.00262	CcSEcCtD
Dofetilide—Anxiety—Sibutramine—obesity	0.00101	0.00261	CcSEcCtD
Dofetilide—Oedema—Orlistat—obesity	0.00101	0.0026	CcSEcCtD
Dofetilide—Back pain—Bupropion—obesity	0.00101	0.0026	CcSEcCtD
Dofetilide—Oedema—Sibutramine—obesity	0.000973	0.00251	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—COMT—obesity	0.000973	0.0087	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Orlistat—obesity	0.000972	0.00251	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—GNB3—obesity	0.000959	0.00858	CbGpPWpGaD
Dofetilide—Shock—Sibutramine—obesity	0.000958	0.00247	CcSEcCtD
Dofetilide—Dronedarone—ALB—obesity	0.000957	0.13	CrCbGaD
Dofetilide—Angioedema—Bupropion—obesity	0.00095	0.00245	CcSEcCtD
Dofetilide—Hyperhidrosis—Sibutramine—obesity	0.000941	0.00243	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—BCHE—obesity	0.000932	0.00834	CbGpPWpGaD
Dofetilide—Syncope—Bupropion—obesity	0.000932	0.00241	CcSEcCtD
Dofetilide—Angina pectoris—Topiramate—obesity	0.000926	0.00239	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—STS—obesity	0.000922	0.00825	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—KCNMA1—obesity	0.000919	0.00822	CbGpPWpGaD
Dofetilide—Palpitations—Bupropion—obesity	0.000919	0.00237	CcSEcCtD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	0.000918	0.00822	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Orlistat—obesity	0.000916	0.00237	CcSEcCtD
Dofetilide—Loss of consciousness—Bupropion—obesity	0.000914	0.00236	CcSEcCtD
Dofetilide—Insomnia—Orlistat—obesity	0.00091	0.00235	CcSEcCtD
Dofetilide—Cough—Bupropion—obesity	0.000907	0.00234	CcSEcCtD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.000907	0.00811	CbGpPWpGaD
Dofetilide—Paraesthesia—Orlistat—obesity	0.000903	0.00233	CcSEcCtD
Dofetilide—Hypertension—Bupropion—obesity	0.000898	0.00232	CcSEcCtD
Dofetilide—KCNH2—Potassium Channels—KCNMA1—obesity	0.000891	0.00797	CbGpPWpGaD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000888	0.00795	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Sibutramine—obesity	0.000887	0.00229	CcSEcCtD
Dofetilide—Arthralgia—Bupropion—obesity	0.000885	0.00228	CcSEcCtD
Dofetilide—Chest pain—Bupropion—obesity	0.000885	0.00228	CcSEcCtD
Dofetilide—Anxiety—Bupropion—obesity	0.000882	0.00228	CcSEcCtD
Dofetilide—Insomnia—Sibutramine—obesity	0.00088	0.00227	CcSEcCtD
Dofetilide—Paraesthesia—Sibutramine—obesity	0.000874	0.00226	CcSEcCtD
Dofetilide—Dyspnoea—Sibutramine—obesity	0.000868	0.00224	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ACADM—obesity	0.000862	0.00771	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.00086	0.00769	CbGpPWpGaD
Dofetilide—Pain—Orlistat—obesity	0.00086	0.00222	CcSEcCtD
Dofetilide—Oedema—Bupropion—obesity	0.000848	0.00219	CcSEcCtD
Dofetilide—Shock—Bupropion—obesity	0.000835	0.00215	CcSEcCtD
Dofetilide—Pain—Sibutramine—obesity	0.000832	0.00215	CcSEcCtD
Dofetilide—Urinary tract infection—Topiramate—obesity	0.000824	0.00213	CcSEcCtD
Dofetilide—Gastrointestinal pain—Orlistat—obesity	0.000822	0.00212	CcSEcCtD
Dofetilide—Hyperhidrosis—Bupropion—obesity	0.00082	0.00212	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000817	0.00731	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—SLC22A1—obesity	0.000802	0.00717	CbGpPWpGaD
Dofetilide—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000797	0.00713	CbGpPWpGaD
Dofetilide—KCNH2—cardiovascular system—obesity	0.000796	0.0449	CbGeAlD
Dofetilide—Gastrointestinal pain—Sibutramine—obesity	0.000796	0.00205	CcSEcCtD
Dofetilide—Abdominal pain—Orlistat—obesity	0.000795	0.00205	CcSEcCtD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000787	0.00704	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000787	0.00704	CbGpPWpGaD
Dofetilide—Bradycardia—Topiramate—obesity	0.000775	0.002	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Bupropion—obesity	0.000773	0.002	CcSEcCtD
Dofetilide—Abdominal pain—Sibutramine—obesity	0.000769	0.00199	CcSEcCtD
Dofetilide—Insomnia—Bupropion—obesity	0.000767	0.00198	CcSEcCtD
Dofetilide—Paraesthesia—Bupropion—obesity	0.000762	0.00197	CcSEcCtD
Dofetilide—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000758	0.00678	CbGpPWpGaD
Dofetilide—Dyspnoea—Bupropion—obesity	0.000756	0.00195	CcSEcCtD
Dofetilide—Oedema peripheral—Topiramate—obesity	0.00075	0.00193	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—COMT—obesity	0.000745	0.00667	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—GNB3—obesity	0.000735	0.00658	CbGpPWpGaD
Dofetilide—Pain—Bupropion—obesity	0.000726	0.00187	CcSEcCtD
Dofetilide—Asthenia—Orlistat—obesity	0.000722	0.00186	CcSEcCtD
Dofetilide—KCNH2—pituitary gland—obesity	0.000705	0.0398	CbGeAlD
Dofetilide—Asthenia—Sibutramine—obesity	0.000698	0.0018	CcSEcCtD
Dofetilide—Gastrointestinal pain—Bupropion—obesity	0.000694	0.00179	CcSEcCtD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—PRKCB—obesity	0.00069	0.00618	CbGpPWpGaD
Dofetilide—Diarrhoea—Orlistat—obesity	0.000688	0.00178	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000673	0.00602	CbGpPWpGaD
Dofetilide—Abdominal pain—Bupropion—obesity	0.000671	0.00173	CcSEcCtD
Dofetilide—Diarrhoea—Sibutramine—obesity	0.000666	0.00172	CcSEcCtD
Dofetilide—Dizziness—Orlistat—obesity	0.000665	0.00172	CcSEcCtD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000652	0.00583	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GABRA6—obesity	0.000646	0.00578	CbGpPWpGaD
Dofetilide—Dizziness—Sibutramine—obesity	0.000644	0.00166	CcSEcCtD
Dofetilide—Back pain—Topiramate—obesity	0.000641	0.00165	CcSEcCtD
Dofetilide—Rash—Orlistat—obesity	0.000634	0.00164	CcSEcCtD
Dofetilide—Dermatitis—Orlistat—obesity	0.000633	0.00164	CcSEcCtD
Dofetilide—Headache—Orlistat—obesity	0.00063	0.00163	CcSEcCtD
Dofetilide—KCNH2—adrenal gland—obesity	0.00063	0.0355	CbGeAlD
Dofetilide—Rash—Sibutramine—obesity	0.000614	0.00158	CcSEcCtD
Dofetilide—Dermatitis—Sibutramine—obesity	0.000613	0.00158	CcSEcCtD
Dofetilide—Headache—Sibutramine—obesity	0.00061	0.00157	CcSEcCtD
Dofetilide—Asthenia—Bupropion—obesity	0.000609	0.00157	CcSEcCtD
Dofetilide—Nausea—Orlistat—obesity	0.000597	0.00154	CcSEcCtD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000596	0.00533	CbGpPWpGaD
Dofetilide—Syncope—Topiramate—obesity	0.000594	0.00153	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—BCHE—obesity	0.000592	0.0053	CbGpPWpGaD
Dofetilide—Palpitations—Topiramate—obesity	0.000585	0.00151	CcSEcCtD
Dofetilide—Loss of consciousness—Topiramate—obesity	0.000582	0.0015	CcSEcCtD
Dofetilide—Diarrhoea—Bupropion—obesity	0.000581	0.0015	CcSEcCtD
Dofetilide—Nausea—Sibutramine—obesity	0.000578	0.00149	CcSEcCtD
Dofetilide—Cough—Topiramate—obesity	0.000578	0.00149	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000577	0.00516	CbGpPWpGaD
Dofetilide—Hypertension—Topiramate—obesity	0.000572	0.00148	CcSEcCtD
Dofetilide—Arthralgia—Topiramate—obesity	0.000564	0.00146	CcSEcCtD
Dofetilide—Chest pain—Topiramate—obesity	0.000564	0.00146	CcSEcCtD
Dofetilide—Anxiety—Topiramate—obesity	0.000562	0.00145	CcSEcCtD
Dofetilide—Dizziness—Bupropion—obesity	0.000561	0.00145	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	0.00055	0.00492	CbGpPWpGaD
Dofetilide—KCNH2—endocrine gland—obesity	0.000546	0.0308	CbGeAlD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.000542	0.00485	CbGpPWpGaD
Dofetilide—Oedema—Topiramate—obesity	0.000541	0.0014	CcSEcCtD
Dofetilide—Rash—Bupropion—obesity	0.000535	0.00138	CcSEcCtD
Dofetilide—Dermatitis—Bupropion—obesity	0.000534	0.00138	CcSEcCtD
Dofetilide—Shock—Topiramate—obesity	0.000532	0.00137	CcSEcCtD
Dofetilide—Headache—Bupropion—obesity	0.000532	0.00137	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—PRKCB—obesity	0.000529	0.00473	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Topiramate—obesity	0.000523	0.00135	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.000518	0.00464	CbGpPWpGaD
Dofetilide—Nausea—Bupropion—obesity	0.000504	0.0013	CcSEcCtD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	0.0005	0.00448	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000499	0.00446	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.000494	0.00442	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Topiramate—obesity	0.000492	0.00127	CcSEcCtD
Dofetilide—Insomnia—Topiramate—obesity	0.000489	0.00126	CcSEcCtD
Dofetilide—Paraesthesia—Topiramate—obesity	0.000485	0.00125	CcSEcCtD
Dofetilide—Dyspnoea—Topiramate—obesity	0.000482	0.00124	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CPT1A—obesity	0.000482	0.00431	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—COMT—obesity	0.000473	0.00424	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GCK—obesity	0.00047	0.0042	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—GNB3—obesity	0.000467	0.00418	CbGpPWpGaD
Dofetilide—Pain—Topiramate—obesity	0.000462	0.00119	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—GLUL—obesity	0.000461	0.00412	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—obesity	0.000455	0.00407	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—GNB3—obesity	0.000453	0.00405	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	0.000452	0.00404	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—NQO1—obesity	0.00045	0.00403	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TF—obesity	0.000448	0.00401	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Topiramate—obesity	0.000442	0.00114	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	0.000439	0.00393	CbGpPWpGaD
Dofetilide—Abdominal pain—Topiramate—obesity	0.000427	0.0011	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000421	0.00377	CbGpPWpGaD
Dofetilide—CYP3A4—Xenobiotics—CYP2E1—obesity	0.000418	0.00374	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—NTRK2—obesity	0.00041	0.00366	CbGpPWpGaD
Dofetilide—CYP3A4—digestive system—obesity	0.00041	0.0231	CbGeAlD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	0.000402	0.0036	CbGpPWpGaD
Dofetilide—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	0.0004	0.00358	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	0.000393	0.00352	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNMA1—obesity	0.000389	0.00348	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—ECHS1—obesity	0.000388	0.00347	CbGpPWpGaD
Dofetilide—Asthenia—Topiramate—obesity	0.000388	0.001	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ESR2—obesity	0.000378	0.00338	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—COMT—obesity	0.000377	0.00337	CbGpPWpGaD
Dofetilide—Diarrhoea—Topiramate—obesity	0.00037	0.000955	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—HADH—obesity	0.000365	0.00326	CbGpPWpGaD
Dofetilide—Dizziness—Topiramate—obesity	0.000357	0.000923	CcSEcCtD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	0.000356	0.00319	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	0.000352	0.00315	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	0.000347	0.00311	CbGpPWpGaD
Dofetilide—Rash—Topiramate—obesity	0.000341	0.00088	CcSEcCtD
Dofetilide—Dermatitis—Topiramate—obesity	0.000341	0.000879	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—SLC22A1—obesity	0.00034	0.00304	CbGpPWpGaD
Dofetilide—Headache—Topiramate—obesity	0.000339	0.000874	CcSEcCtD
Dofetilide—CYP3A4—endocrine gland—obesity	0.000338	0.0191	CbGeAlD
Dofetilide—KCNK2—Neuronal System—PRKCB—obesity	0.000336	0.00301	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AR—obesity	0.000334	0.00299	CbGpPWpGaD
Dofetilide—Nausea—Topiramate—obesity	0.000321	0.000829	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000315	0.00282	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GNB3—obesity	0.000315	0.00282	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—BDNF—obesity	0.000306	0.00274	CbGpPWpGaD
Dofetilide—CYP3A4—liver—obesity	0.000305	0.0172	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL10—obesity	0.000292	0.00261	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	0.000285	0.00255	CbGpPWpGaD
Dofetilide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	0.000278	0.00249	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	0.000274	0.00245	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—NR3C1—obesity	0.00027	0.00242	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—obesity	0.000266	0.00238	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	0.00026	0.00232	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HTR2A—obesity	0.000258	0.00231	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—BCHE—obesity	0.000251	0.00224	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	0.00025	0.00224	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	0.000235	0.0021	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	0.000215	0.00192	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	0.000212	0.0019	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—COMT—obesity	0.0002	0.00179	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—GNB3—obesity	0.000198	0.00177	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	0.000192	0.00171	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	0.00018	0.00161	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	0.000174	0.00155	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	0.000171	0.00153	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	0.000157	0.00141	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	0.000155	0.00139	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1B—obesity	0.000153	0.00137	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	0.000153	0.00137	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP26B1—obesity	0.000151	0.00136	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	0.000149	0.00134	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	0.000149	0.00133	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—PRKCB—obesity	0.000142	0.00127	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	0.000141	0.00126	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—ADH1B—obesity	0.000133	0.00119	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	0.000127	0.00114	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	0.000126	0.00112	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TNF—obesity	0.000111	0.000994	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—SULT2A1—obesity	0.000102	0.000916	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	0.000101	0.000903	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX3—obesity	9.63e-05	0.000861	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	9.31e-05	0.000833	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6—obesity	8.96e-05	0.000802	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	8.44e-05	0.000755	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	7.55e-05	0.000675	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2E1—obesity	7.48e-05	0.000669	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	7.38e-05	0.00066	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GGT1—obesity	6.87e-05	0.000615	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—NCOA1—obesity	6.77e-05	0.000605	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP19A1—obesity	6.67e-05	0.000597	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	6.58e-05	0.000588	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CA3—obesity	6.24e-05	0.000558	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—COMT—obesity	6.2e-05	0.000555	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—COMT—obesity	6.11e-05	0.000547	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GLRX—obesity	5.31e-05	0.000475	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—OTC—obesity	4.73e-05	0.000423	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—INSIG2—obesity	4.73e-05	0.000423	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ETFDH—obesity	4.73e-05	0.000423	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPM1L—obesity	4.73e-05	0.000423	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—INPP5E—obesity	4.32e-05	0.000387	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPT—obesity	4.32e-05	0.000387	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UQCRC2—obesity	4.32e-05	0.000387	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ME1—obesity	4.02e-05	0.00036	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDH6A1—obesity	4.02e-05	0.00036	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SUCLG2—obesity	4.02e-05	0.00036	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—POMC—obesity	4.01e-05	0.000359	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UCP1—obesity	3.78e-05	0.000338	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COX7C—obesity	3.78e-05	0.000338	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PNPLA3—obesity	3.78e-05	0.000338	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DGAT2—obesity	3.58e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CS—obesity	3.58e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CPS1—obesity	3.58e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SUCLA2—obesity	3.58e-05	0.000321	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MUT—obesity	3.42e-05	0.000306	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LIPE—obesity	3.42e-05	0.000306	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DGAT1—obesity	3.28e-05	0.000293	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYB5A—obesity	3.28e-05	0.000293	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACLY—obesity	3.15e-05	0.000282	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ENPP1—obesity	3.05e-05	0.000273	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALOX12—obesity	3.05e-05	0.000273	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMGCS1—obesity	2.95e-05	0.000264	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACADM—obesity	2.86e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PFKFB3—obesity	2.86e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ANGPTL4—obesity	2.86e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLIN1—obesity	2.86e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SAT1—obesity	2.86e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PNPLA2—obesity	2.86e-05	0.000256	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACACB—obesity	2.79e-05	0.000249	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—OXCT1—obesity	2.79e-05	0.000249	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYTB—obesity	2.79e-05	0.000249	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PNLIP—obesity	2.72e-05	0.000243	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SRD5A1—obesity	2.72e-05	0.000243	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SDC3—obesity	2.65e-05	0.000237	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HK2—obesity	2.59e-05	0.000232	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STS—obesity	2.59e-05	0.000232	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP26B1—obesity	2.59e-05	0.000232	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARD—obesity	2.54e-05	0.000227	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC27A1—obesity	2.48e-05	0.000222	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GLUL—obesity	2.44e-05	0.000218	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FABP4—obesity	2.44e-05	0.000218	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ECHS1—obesity	2.31e-05	0.000207	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UCP2—obesity	2.31e-05	0.000207	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UCP3—obesity	2.31e-05	0.000207	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HSD11B1—obesity	2.31e-05	0.000207	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADH1B—obesity	2.27e-05	0.000203	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPAM—obesity	2.24e-05	0.0002	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACSL1—obesity	2.24e-05	0.0002	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARGC1B—obesity	2.24e-05	0.0002	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FADS1—obesity	2.17e-05	0.000194	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PCK1—obesity	2.17e-05	0.000194	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HADH—obesity	2.17e-05	0.000194	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACP5—obesity	2.11e-05	0.000189	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—G6PD—obesity	2.06e-05	0.000184	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HK1—obesity	2.03e-05	0.000182	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SREBF2—obesity	2.03e-05	0.000182	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LPA—obesity	1.96e-05	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LPIN1—obesity	1.92e-05	0.000172	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA5—obesity	1.88e-05	0.000168	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC22A1—obesity	1.8e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CLOCK—obesity	1.8e-05	0.000161	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SULT2A1—obesity	1.75e-05	0.000157	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GLP1R—obesity	1.75e-05	0.000157	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DPYD—obesity	1.72e-05	0.000154	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PRKAR2B—obesity	1.66e-05	0.000148	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DCN—obesity	1.65e-05	0.000147	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CPT1A—obesity	1.6e-05	0.000143	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NAMPT—obesity	1.57e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LIPC—obesity	1.56e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GCK—obesity	1.56e-05	0.00014	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOC3—obesity	1.55e-05	0.000139	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CETP—obesity	1.5e-05	0.000135	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SDC1—obesity	1.49e-05	0.000133	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKR1C3—obesity	1.46e-05	0.000131	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SCARB1—obesity	1.44e-05	0.000129	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SREBF1—obesity	1.4e-05	0.000125	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GOT2—obesity	1.36e-05	0.000122	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FASN—obesity	1.33e-05	0.000119	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—BCHE—obesity	1.33e-05	0.000119	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2E1—obesity	1.28e-05	0.000114	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NQO1—obesity	1.27e-05	0.000113	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GCG—obesity	1.21e-05	0.000109	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC2A4—obesity	1.21e-05	0.000109	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYCS—obesity	1.2e-05	0.000107	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GGT1—obesity	1.17e-05	0.000105	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GOT1—obesity	1.17e-05	0.000105	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOA1—obesity	1.16e-05	0.000104	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STK11—obesity	1.14e-05	0.000102	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP19A1—obesity	1.14e-05	0.000102	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COMT—obesity	1.06e-05	9.49e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GNB3—obesity	1.05e-05	9.35e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARGC1A—obesity	1.05e-05	9.35e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMOX1—obesity	1.04e-05	9.31e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GNAS—obesity	1.02e-05	9.11e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOB—obesity	9.97e-06	8.92e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LPL—obesity	9.52e-06	8.52e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX1—obesity	9.29e-06	8.31e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CD36—obesity	9.04e-06	8.09e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTHFR—obesity	8.57e-06	7.67e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARA—obesity	8.41e-06	7.52e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AGT—obesity	8.14e-06	7.29e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOE—obesity	7.98e-06	7.14e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CAV1—obesity	7.91e-06	7.07e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APOA1—obesity	7.89e-06	7.06e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CG—obesity	7.2e-06	6.44e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARG—obesity	6.95e-06	6.22e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—POMC—obesity	6.85e-06	6.13e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—INS—obesity	6.82e-06	6.1e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CD—obesity	6.33e-06	5.66e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALB—obesity	6.25e-06	5.59e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NOS3—obesity	5.98e-06	5.35e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3R1—obesity	5.98e-06	5.35e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CB—obesity	5.52e-06	4.94e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS2—obesity	5.47e-06	4.89e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CA—obesity	3.36e-06	3.01e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—obesity	2.75e-06	2.46e-05	CbGpPWpGaD
